Clinical Trial Update: DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril [Phase 3]

View source ↗

Summary

Phase 3 DETAIL trial evaluating exposure to telmisartan and enalapril in patients with hypertension and type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Enalapril (enalapril)
• Telmisartan (Telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED